Laser removal of psoriasis tissue with fluorescence help
Part of Skin clinical trials.
This study tests whether a special fluorescence technique can help doctors more precisely remove psoriasis plaques with a laser. It may lead to better healing and less damage to healthy skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have psoriasis (any severity) with at least three visible spots on your torso, arms, legs, face, or buttocks.
- You are not pregnant or breastfeeding.
- You have fair to medium skin (Fitzpatrick type 4 or lower).
- You do not have other autoimmune diseases, psoriatic arthritis, or diabetes type 2.
- You do not smoke heavily, have active infections in the treatment area, or take certain medications like blood thinners or immunosuppressants.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding a fractional CO₂ laser (a type of laser that creates tiny holes in skin) to a steroid cream works better than the cream alone for treating psoriasis on the palms and soles. The goal is to see if the laser can improve stubborn hand and foot psoriasis.
This trial tests a new laser (PALLAS) that delivers targeted UVB light to treat skin conditions like psoriasis or eczema. It may help if your doctor thinks your skin problem could improve with UVB therapy.
This study looks at how blood sugar control (including diabetes) changes immune cells in the skin for people with moderate to severe plaque psoriasis. It may help researchers understand what drives psoriasis and how it could respond to future treatments.
This study looks at how inflammation-related genes behave in people with psoriasis. It may help researchers understand why psoriasis flares and how it could be better treated.
This study looks at skin cells at the single-cell level to predict which psoriasis treatments will work best for you. It may help doctors personalize treatment choices for plaque psoriasis.
This study tests whether narrowband ultraviolet B (UVB) light given three times a week for 12 weeks improves moderate-to-severe plaque psoriasis. It is an “open-label” pilot, meaning everyone gets the UVB treatment and researchers track how your skin responds.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.